Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide
Authors
Keywords
-
Journal
JOURNAL OF GENE MEDICINE
Volume 19, Issue 3, Pages e2942
Publisher
Wiley
Online
2017-01-14
DOI
10.1002/jgm.2942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy
- (2016) J. Y. Yoo et al. CLINICAL CANCER RESEARCH
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- T-VEC oncolytic viral therapy shows promise in melanoma
- (2015) David Killock Nature Reviews Clinical Oncology
- Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
- (2015) Aurelie Poli et al. Oncotarget
- Intracellular and extracellular domains of protein tyrosine phosphatase PTPRZ-B differentially regulate glioma cell growth and motility
- (2015) Annika M. Bourgonje et al. Oncotarget
- Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells
- (2014) Lei Wu et al. TUMOR BIOLOGY
- Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma
- (2014) Justyna Kmiecik et al. OncoImmunology
- Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: A population-based analysis
- (2013) Derek R. Johnson et al. CANCER
- Proteoglycans and their roles in brain cancer
- (2013) Anna Wade et al. FEBS Journal
- Fibulin-3 Promotes Glioma Growth and Resistance through a Novel Paracrine Regulation of Notch Signaling
- (2012) B. Hu et al. CANCER RESEARCH
- Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
- (2012) Balveen Kaur et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Glycosaminoglycans: key players in cancer cell biology and treatment
- (2012) Nikos Afratis et al. FEBS Journal
- Chondroitin sulphate proteoglycans: Extracellular matrix proteins that regulate immunity of the central nervous system
- (2011) Sarah Haylock-Jacobs et al. AUTOIMMUNITY REVIEWS
- Influence of chondroitin sulfate and hyaluronic acid on structure, mechanical properties, and glioma invasion of collagen I gels
- (2011) Ya-li Yang et al. BIOMATERIALS
- A Novel Oncolytic Herpes Simplex Virus that Synergizes with Phosphoinositide 3-kinase/Akt Pathway Inhibitors to Target Glioblastoma Stem Cells
- (2011) R. Kanai et al. CLINICAL CANCER RESEARCH
- Oncolytic Virus-Mediated Manipulation of DNA Damage Responses: Synergy With Chemotherapy in Killing Glioblastoma Stem Cells
- (2011) Ryuichi Kanai et al. JNCI-Journal of the National Cancer Institute
- Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres
- (2010) Alicia M. Mihaliak et al. CANCER LETTERS
- Chondroitinase ABC I–Mediated Enhancement of Oncolytic Virus Spread and Antitumor Efficacy
- (2010) Nina Dmitrieva et al. CLINICAL CANCER RESEARCH
- Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
- (2010) Achilleas D. Theocharis et al. FEBS Journal
- Modification of N-glycosylation sites allows secretion of bacterial chondroitinase ABC from mammalian cells
- (2009) Elizabeth M. Muir et al. JOURNAL OF BIOTECHNOLOGY
- Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells
- (2008) M A Westhoff et al. ONCOGENE
- The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
- (2008) M Chekenya et al. ONCOGENE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search